
Starting April 1, 2026, China's National Medical Products Administration (NMPA) will classify radiofrequency (RF) therapy devices and RF skin treatment devices as Class III medical devices, requiring manufacturers to obtain medical device registration certificates. This policy shift impacts domestic producers exporting to markets like the EU, Middle East, and Southeast Asia, where these products were previously registered as household appliances. The change mandates stricter quality control, clinical evaluations, and labeling compliance. Industry players—particularly exporters, OEMs, and overseas importers—must adapt to avoid supply chain disruptions and regulatory penalties.
As confirmed by the NMPA, RF beauty devices will be reclassified under Class III medical device management from April 1, 2026. Manufacturers must secure registration certificates to continue production, sales, or exports. Products lacking certification will be banned from the Chinese market and face export restrictions. Notably, this affects devices previously labeled as household appliances, now subject to medical-grade standards, including clinical trials and factory inspections.
Chinese OEMs supplying RF devices to international markets must overhaul production lines to meet medical device standards. From an industry perspective, this entails:
EU and Middle Eastern buyers sourcing from China face:
Logistics and certification agencies must prepare for:
Importers should audit Chinese manufacturers' registration progress. Current priorities include:
With clinical evaluations potentially taking 12–18 months, buyers may need to:
NMPA may issue细化规则 (detailed rules) for transitional arrangements. Watching for:
Analysis suggests this policy reflects China's alignment with global medical device trends, similar to the EU's MDR. However:
China's RF device reclassification underscores tightening cross-border health product regulations. While the policy aims to standardize quality, its ripple effects will reshape export dynamics—particularly for beauty tech OEMs and their global partners. Stakeholders should approach this as a phased transition, prioritizing certification readiness and supplier dialogue over reactive measures.
National Medical Products Administration (NMPA) official announcement. Pending clarification: Whether non-invasive RF devices (e.g., home-use beauty tools) face lower-tier classification.
Related Intelligence